AI assistant
Sending…
Kamada Ltd. — Earnings Release 2022
Nov 22, 2022
6874_rns_2022-11-22_2592426e-4acc-4cf1-807f-669731d06cbf.htm
Earnings Release
Open in viewerOpens in your device viewer
Kamada Reports Strong Third Quarter Financial Results Demonstrating Successful Strategic Transition and Reiterates 2022 Financial Guidance false
| ����� ��"� | 2 380 |
| KAMADA LTD | |
| Corporation no: 511524605 | 14096 |
| - - - | |
| Israel Securities Authority | Tel Aviv Stock Exchange | C002 ( Public ) | Reported via MAGNA: | 22/11/2022 | ||||||
| www.isa.gov.il | www.tase.co.il | Reference: | 2022-02-111981 | Time of broadcast: 13:57 13:57 |
Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000
| The corporation is a foreign private issuer as defined by U.S. Securities Laws. |
Attached hereto is a report onKamada Reports Strong Third Quarter Financial Results Demonstrating Successful Strategic Transition and Reiterates 2022 Financial Guidance
ea168808-6k_kamadaltdEDGAR13_Bannerless_isa.pdf
| References of previous documents relating to this matter(the reference does not constitute incorporation by reference): | |
| - - - | |
| Stock Exchange/Market: TASE | Date of revision of form structure: 02/11/2022 |
| Address: Holtzman 2 4081 , Rehovot 7670402 ISRAEL , Tel: 08-9406472 , Fax: 08-9406473 | |
| E-mail address: [email protected] Company site: www.kamada.com | |
| Previous names of reporting entity: | |
| Name of the Signatory: REFAEL MOSHE Position of Signatory in the reporting corporation: Company Controller Name of Employer Company: | |
| Address: Holtzman 2 , Rehovot 7670402 Telephone: 08-9406472 Facsimile: 08-9406473 E-mail: [email protected] 1 | |
More from Kamada Ltd.
Report Publication Announcement
2026
May 13
Earnings Release
2026
May 13
Report Publication Announcement
2026
May 13
Regulatory Filings
2026
May 6
Report Publication Announcement
2026
May 6
Director's Dealing
2026
Apr 16
Report Publication Announcement
2026
Apr 16
Director's Dealing
2026
Apr 9
Director's Dealing
2026
Apr 9
Regulatory Filings
2026
Mar 31